Table 4.

Seroprevalence and viraemic prevalence per sex and per age category

	Serology		Viraemia
	N	Prevalence CI95%	N	Prevalence CI95%
Overall	221/5098	2.61 [2.25–2.96]	157/5098	1.88 [1.62–2.14]
[18–44]	5/859	0.58 [0.27–0.89]	4/859	0.47 [0.17–0.76]
[45+]	216/4239	5.10 [4.55–5.65]	153/4239	3.62 [3.22–4.01]
Male	112/2159	3.03 [2.54–3.52]	84/2159	2.37 [1.94–2.79]
Female	109/2939	2.27 [1.87–2.66]	73/2939	1.49 [1.22–1.76]